Koers Aurora Cannabis Inc Other OTC
Aandelen
CA05156X1087
Farmaceutische producten
Omzet 2024 * | 272 mln. 198 mln. 185 mln. | Omzet 2025 * | 320 mln. 233 mln. 218 mln. | Marktkapitalisatie | 429 mln. 312 mln. 292 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -61 mln. -44,4 mln. -41,52 mln. | Nettowinst (verlies) 2025 * | -7 mln. -5,09 mln. -4,76 mln. | EV/omzet 2024 * | 1,58 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,34 x |
K/w-verhouding 2024 * |
-5,03
x | K/w-verhouding 2025 * |
-48,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Aurora Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 06-07-20 |
Simona King
DFI | Director of Finance/CFO | 52 | 21/02 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 25-07-18 |
Michael Singer
BRD | Director/Board Member | 60 | 20-05-16 |
Adam Szweras
BRD | Director/Board Member | 52 | 10-08-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,48% | 5,8 mld. | |
-26,22% | 3,92 mld. | |
+4,73% | 3,28 mld. | |
-20,86% | 2,77 mld. | |
-11,88% | 2,26 mld. | |
+46,64% | 1,95 mld. | |
-16,71% | 1,52 mld. | |
+44,65% | 1,49 mld. | |
-9,60% | 1,49 mld. |